Skip to main content

Iveda Solutions, Inc.

For the period ended Sep 30, 2025. Filed Nov 14, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 14, 2025

IVDA$0.22+7.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 1. FINANCIAL STATEMENTS

ITEM 1.FINANCIAL STATEMENTS.

CONDENSED CONSOLIDATED BALANCE SHEETS

September 30, 2025December 31, 2024
(UNAUDITED)
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents$3,298,474$2,629,287
Restricted Cash32,80229,013
Accounts Receivable, Net1,324,0861,277,635
Deferred Cost of Goods237,749507,308
Inventory, Net247,516148,120
Other Current Assets340,592435,052
Total Current Assets5,481,2195,026,415
Property and Equipment, Net53,20168,677
Right of Use Asset, Net159,263
Other Assets84,69684,424
Total Assets$5,778,379$5,179,516
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts and Other Payables$1,240,902$1,748,857
Short Term Debt164,134427,025
Current Portion of Long-Term Debt131,307122,007
Current Portion of Lease Liability40,390
Total Current Liabilities1,576,7332,297,889
Long Term Debt306,382376,188
Long Term Lease Liability, Net of Current Portion127,022-
Total Liabilities2,010,1372,674,077
STOCKHOLDERS’ EQUITY
Preferred Stock, $0.00001 par value; 12,500,000 shares authorized, no preferred shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively--
Common Stock, $0.00001 par value; 300,000,000 shares authorized; 4,457,444 and 2,808,071 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively4528
Additional Paid-In Capital58,736,16655,962,337
Accumulated Other Comprehensive Loss(212,027)(280,209)
Accumulated Deficit(54,755,942)(53,176,717)
Total Stockholders’ Equity3,768,2422,505,439
Total Liabilities and Stockholders’ Equity$5,778,379$5,179,516

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

For the Three Months ended September 30, 2025For the Three Months ended September 30, 2024For the Nine Months ended September 30, 2025For the Nine Months ended September 30, 2024
REVENUE
Equipment Sales (including sales to Iveda Philippines of $0 and $188,445 for the three and nine months ended September 30, 2025, respectively.$1,522,776$2,336,590$4,380,506$4,008,978
Service Revenue129,01161,572273,764270,005
TOTAL REVENUE1,651,7872,398,1624,654,2704,278,983
COST OF REVENUE1,134,5101,987,6803,404,0123,185,443
GROSS PROFIT517,277410,4821,250,2581,093,540
OPERATING EXPENSES
General & Administrative705,830980,1652,722,2293,303,397
Research & Development25,75039,250110,250339,350
Total Operating Expenses731,5801,019,4152,832,4793,642,747
LOSS FROM OPERATIONS(214,303)(608,932)(1,582,221)(2,549,207)
OTHER INCOME (EXPENSE)
Miscellaneous Income (Expense)(22)8,36932,12534,157
Interest Income5,26024,90530,80192,919
Interest Expense(11,574)(5,846)(29,487)(15,355)
Total Other Income (Expense), Net(6,336)27,42833,439111,721
LOSS BEFORE INCOME TAXES$(220,639)$(581,504)$(1,548,782)$(2,437,486)
PROVISION FOR INCOME TAXES(665)131(30,443)(32,464)
NET LOSS$(221,304)$(581,373)$(1,579,225)$(2,469,950)
BASIC AND DILUTED LOSS PER SHARE$(0.07)$(0.27)$(0.54)$(1.20)
WEIGHTED AVERAGE SHARES3,045,7532,115,3072,897,8872,055,649

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

For the Three Months ended September 30, 2025For the Three Months ended September 30, 2024For the Nine months ended September 30, 2025For the Nine months ended September 30, 2024
Net Loss$(221,304)$(581,373)$(1,579,225)$(2,469,950)
Other Comprehensive Loss
Change in Equity Adjustment from Foreign Currency Translation, Net of Tax(41,262)28,95368,182(26,655)
Comprehensive Loss$(262,566)$(552,420)$(1,511,043)$(2,496,605)

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements*.***

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

Accumulated
Common · Additional · Other · Total
CommonStockPaid-in-AccumulatedComprehensiveStockholders’
StockAmountCapitalDeficit(Loss)Equity
BALANCE AT December 31, 20232,021,236$20$54,065,775$(49,195,897)$(221,418)$4,648,480
Cost of Financing--(3,690)--(3,690)
Net Loss---(1,289,596)-(1,289,596)
Comprehensive Loss----(34,591)(34,591)
BALANCE AT March 31, 20242,021,236$20$54,062,085$(50,485,493)$(256,009)$3,320,603
Common Stock for Services12,500-90,000--90,000
Stock Compensation Expense--25,600--25,600
Net Loss---(598,981)(598,981)
Comprehensive Loss----(21,018)(21,018)
BALANCE AT June 30, 20242,033,736$20$54,062,085$(51,084,474)$(277,027)$2,816,204
Common Stock Issued in September 2024 offering225,0002773,998774,000
Pre-Funded Warrrants – 450,0001,372,8001,372,800
Cost of Financing12,500-(312,340)--(312,500)
Reverse Split Fractional shares149,3352(2)---
Net Loss---(581,373)(581,373)
Comprehensive Loss----28,70128,701
BALANCE AT September 30, 20242,408,071$24$56,012,143$(51,665,848)$(248,072)$4,098,246
BALANCE AT December 31, 20242,808,071$28$55,962,337$(53,176,717)$(280,209)$2,505,439
Net Loss---(793,672)-(793,672)
Comprehensive Loss----(10,880)(10,880)
BALANCE AT March 31, 20252,808,071$28$55,962,337$(53,970,389)$(291,089)$1,700,887
Sale of Common Stock98,6551223,594223,595
Net Loss(564,249)(564,249)
Comprehensive Loss120,324120,324
BALANCE AT June 30, 20252,906,726$29$56,185,931$(54,534,638)$(170,765)$1,480,557
Sale of Common Stock1,500,718152,482,7352,482,750
Stock for Services50,000167,50067,500
Net Loss(221,304)(221,304)
Comprehensive Loss(41,262)(41,262)
BALANCE AT September 30, 20254,457,444$45$58,736,166$(54,755,942)$(212,027)$3,768,242

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE NINE MONTHS ENDING SEPTEMBER 30, 2025 AND 2024 (UNAUDITED)

September 30, 2025September 30, 2024
(Restated)
CASH FLOWS FROM OPERATING ACTIVITIES
Net Loss$(1,579,225)$(2,469,950)
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities
Depreciation and Amortization16,06223,806
Stock Compensation Expense25,600
Common Stock for Services67,50090,000
Changes in operating assets and liabilities
Accounts Receivable(46,451)(1,872,233)
Inventory(99,396)(971,616)
Deferred Cost of Goods269,559-
Right of Use Asset23,405-
Other Current Assets96,950(113,064)
Other Assets(272)208,762
Increase (Decrease) in Accounts and Other Payables(507,956)1,548,762
Lease Liability(15,256)-
Net Cash Used in Operating Activities(1,775,080)(3,529,933)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of Property and Equipment-(2,615)
Net Cash Used in Investing Activities-(2,615)
CASH FLOWS FROM FINANCING ACTIVITIES
Payments on Short-Term Debt, net(335,520)(53,135)
Proceeds from Short-Term Debt72,629
Proceeds from (Payments on) Long-Term Debt(60,506)541,449
Common Stock Issued, Net of Cost of Financing2,706,3461,830,770
Net Cash Provided by Financing Activities2,382,9492,319,084
EFFECT OF EXCHANGE RATE CHANGES ON CASH65,107(25,607)
NET DECREASE IN CASH, RESTRICTED CASH AND CASH EQUIVALENTS672,976(1,239,071)
Cash, Restricted Cash and Cash Equivalents- Beginning of Period2,658,3004,868,282
CASH, RESTRICTED CASH AND CASH EQUIVALENTS - END OF PERIOD$3,331,276$3,629,211

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - CONTINUED

FOR THE NINE MONTHS ENDING SEPTEMBER 30, 2025 AND 2024 (UNAUDITED)

September 30, 2025 · September 30, 2024
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Interest Paid$14,732$15,355
Income Tax Paid$12,434$36,942
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES
Present Value of Right of Use Asset and Lease Obligations on New Lease$182,668$-

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE AND NINE MONTHS ENDING SEPTEMBER 30, 2025 AND 2024 (UNAUDITED)

NOTE 1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Iveda Solutions, Inc. (“Iveda”, or the “Company”) was incorporated in Nevada as Charmed Homes, Inc. in June 2006. On October 15, 2009, IntelaSight, d/b/a Iveda, a Washington corporation, became a wholly owned subsidiary of the Company. In December 2010, IntelaSight merged with and into the Company and the Company became the surviving company. Iveda offered the first cloud hosting of streaming and recorded video from security cameras for its customers and real-time remote surveillance service utilizing intervention specialists to watch our customers’ cameras in real time, 24/7. Iveda offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide.

Effective April 30, 2011, we completed our acquisition of Sole Vision Technologies (fka MEGAsys and dba Iveda Taiwan), a company based in Taiwan. We consolidate our financial statements with the financial statements of Iveda Taiwan. All intercompany balances and transactions have been eliminated in consolidation.

Basis of Presentation

The unaudited condensed financial statements of the Company for the three and nine months ended September 30, 2025 and 2024 have been prepared in accordance with accounting principles generally accepted in the U.S. (“GAAP”) for interim financial information and pursuant to the requirements for reporting on Form 10-Q and Regulation S-K for scaled disclosures for smaller reporting companies. Accordingly, they do not include all the information and footnotes required by GAAP for complete financial statements. However, such information reflects all adjustments (consisting solely of normal recurring adjustments), which are, in the opinion of management, necessary for the fair presentation of the Company’s financial position and results of operations. Results shown for interim periods are not necessarily indicative of the results to be obtained for a full fiscal year. The balance sheet information as of December 31, 2024 was derived from the audited financial statements included in the Company’s financial statements as of and for the years ended December 31, 2024 and 2023 contained in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission. These financial statements should be read in conjunction with that report.

Going Concern

The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplates the continuation of the Company as a going concern. The Company experienced net losses and negative operating cash flows during the nine months ended September 30, 2025, and had an accumulated deficit as of that date. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

At September 30, 2025, the Company had cash on hand in the amount of $3,298,474. Subsequent to September 30, 2025 we raised an additional $2,224,048 net proceeds from the sale of our common shares (See Note 11). Although we believe we now have a strong cash position after the subsequent raise and have experienced an overall improvement in our operations that will result in improved cash flow, Management cannot be certain that its current liquidity will support operations and other future business opportunities from a date of twelve months from the issuance of this financial statement. As a result, management has concluded that there is substantial doubt about the Company’s ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classification of liabilities that might be necessary in the event the company cannot continue as a going concern. The Company’s independent registered public accounting firm, in its report on the Company’s consolidated financial statements for the year ended December 31, 2024, has also expressed substantial doubt about the Company’s ability to continue as a going concern.

The continuation of the Company as a going concern is dependent upon its ability to obtain necessary debt or equity financing to continue operations until it begins generating positive cash flow. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain undue restrictions on our operations in the case of debt financing, or cause substantial dilution for our stockholders, in case of equity financing.

Basis of Accounting

Our consolidated financial statements have been prepared on the accrual basis of accounting in conformity with accounting principles generally accepted in the United States of America.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Accordingly, actual results could differ from those estimates. On an ongoing basis, we evaluate our estimates, including those related to accounts receivable, deferred cost of revenue, share-based compensation, deferred income taxes, provisions for losses, and inventory reserve, among other items.

Revenue and Expense Recognition

The Company applies the provisions of Accounting Standards Codification (ASC) 606-10,Revenue from Contracts with Customers, and all related appropriate guidance. The Company recognizes revenue under the core principle to depict the transfer of control to its customers in an amount reflecting the consideration to which it expects to be entitled. In order to achieve that core principle, the Company applies the following five-step approach: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied.

The Company considers customer purchase orders, which in some cases are governed by master sales agreements, to be the contracts with the customer. In situations where sales are to a distributor, the Company has concluded its contracts are with the distributor as the Company holds a contract bearing enforceable rights and obligations only with the distributor. As part of its consideration for the contract, the Company evaluates certain factors including the customers’ ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations. In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to which it expects to be entitled. As the Company’s standard payment terms are less than one year, it has elected the practical expedient under ASC 606-10-32-18 to not assess whether a contract has a significant financing component. The Company allocates the transaction price to each distinct product based on its relative standalone selling price. The product price as specified on the purchase order is considered the standalone selling price as it is an observable input which depicts the price as if sold to a similar customer in similar circumstances. Revenue is recognized when control of the product is transferred to the customer (i.e., when the Company’s performance obligations is satisfied), which typically occurs at shipment unless installation is required as with certain of our Taiwan sales – see below. Further in determining whether control has been transferred, the Company considers if there is a present right to payment and legal title, along with risks and rewards of ownership having transferred to the customer. Customers do not have a right to return the product other than for warranty reasons for which they would only receive repair services or replacement product. The Company has also elected the practical expedient under ASC 340-40-25-4 to expense commissions for product sales when incurred as the amortization period of the commission asset the Company would have otherwise recognized is less than one year.

The Company sells its products and services primarily to municipalities and commercial customers in the following manner:

●The majority of Iveda Taiwan sales are project sales to Taiwan customers and are made direct to the end customer (typically a municipality or a commercial customer) through its sales force, which is composed of its employees. Revenue is recorded when the equipment is shipped to the end customer unless the contract requires the inventory to be installed before it can be billed and charged for service when installation or maintenance work is performed. If inventory is shipped to the customer before it is installed the inventory is reclassified to Deferred Cost of Goods.

Revenue for product and software sales without installation is recorded when the product and/or software has been shipped to the customer. Revenue from fixed-price equipment installation contracts, if any, is recognized as the contracts allow for invoicing at various milestones.

General and administrative costs are charged to expense as incurred. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability may result in revisions to costs and income and are recognized in the period in which the revisions are determined. Changes in estimated job profitability resulting from job performance, job conditions, contract penalty provisions, claims, change orders, and settlements are accounted for as changes in estimates in the current period. Profit incentives are included in revenue when their realization is deemed earned by the contract.

●Iveda US hardware sales are to domestic and international customers and are made through independent distributors or integrators who purchase products from the Company at a wholesale price and sell to the end user (typically municipalities or a commercial customer) at a retail price. The distributor retains the margin as its compensation for its role in the transaction. The distributor or integrator generally maintains product inventory or product is drop shipped from the manufacturer, customer receivables and all related risks and rewards of ownership. Accordingly, upon application of steps one through five above, revenue is recorded when the product is shipped to the distributor or as directed by the distributor consistent with the terms of the distribution agreement.
●Iveda US also sells software that include licensing fees that are paid either monthly or yearly. The revenues are recorded monthly, if the license is paid yearly the revenue will be recorded as deferred revenue and amortized on a straight-line basis over the respective time period.
●Iveda US also sells hardware and software warranty and maintenance for an annual fee that are paid yearly. The revenues are recorded annually, if the revenue is a material amount it will be recorded as deferred revenue and amortized on a straight-line basis over the respective time period.

The following table presents our net sales by revenue source for the period presented:

For the three months ended September 30, 2025For three months ended September 30, 2024For the nine months ended September 30, 2025For the nine months ended September 30, 2024
Net Sales Source
Commercial Enterprises$1,221,455$2,047,176$2,816,922$3,569,464
Distributors$14,826$311,518$413,288$578,688
Municipalities$51,749$39,468$115,143$123,957
Taiwan Government$363,757$$1,308,917$6,874
Total Net Sales Source$1,651,787$2,398,162$4,654,270$4,278,983

The Company sells and installs video surveillance systems comprised of various components of hardware and software.

Concentrations

Financial instruments, which potentially subject us to concentrations of credit risk, consist principally of cash and cash equivalents and trade accounts receivable.

Substantially all cash is deposited in three financial institutions, two in the United States and one in Taiwan. At times, amounts on deposit in the United States may be in excess of the FDIC insurance limit. Deposits in Taiwan financial institutions are insured by CDIC (Central Deposit Insurance Corporation) with maximum coverage of 3 million New Taiwan Dollar (NTD). At times, amounts on deposit in Taiwan may be in excess of the CDIC Insurance limit.

Revenue from four customers out of approximately 74 total customers represented approximately 66% of total revenue for the nine months ended September 30, 2025. These specific customers were 1) National Chung Shan Institute of Science and Technology with 28%, 2) Taiwan Stock Exchange with 15%, SECURITY INTEGRATION & CONSULTANT TECHNOLOGY CO., LTD. with 13% and Chunghwa Telecom with 10% (all Taiwan companies). Revenue from five customers out of 72 total customers represented approximately 76% of total revenue for the nine months ended September 30, 2024. These specific customers were 1) Security Integration & Consultant Technology CO., LTD. (Taiwan company) with 19%, 2) Chicony Power Technology Co., Ltd. (Taiwan company) with 16%, 3) HWACOM Systems Inc. (Taiwan company) with 15%, 4) Claro Enterprise Solutions with 14% (US Company) and 5) Chunghwa Telecom (Taiwan company) with 13%.

No other customers represented greater than 10% of total revenues the nine months ended September 30, 2025 and 2024.

74% of the total accounts receivable at September 30, 2025 was from three customers out of a total of 42 customer accounts receivable accounts. These specific customers were SECURITY INTEGRATION & CONSULTANT TECHNOLOGY CO., LTD. (33%), Chunghwa Telecom (16%) and National Chung Shan Institute of Science and Technology (25%) (all Taiwan companies). Our accounts receivables are unsecured, and we are at risk to the extent such amounts become uncollectible. Although we perform periodic evaluations of our customers’ credit and financial condition, we do not require collateral in exchange for our products and services provided on credit. These customers are longtime customers, and we don’t expect any problem with the collectability of these accounts receivable.

Loss per share

Basic earnings per share (“EPS”) is computed by dividing reported earnings available to stockholders by the weighted average shares outstanding. We had net losses for the nine months ended September 30, 2025 and 2024 and the effect of including dilutive securities in the earnings per common share would have been anti-dilutive for the purpose of calculating EPS. Accordingly, all options, warrants, and shares potentially convertible into common shares were excluded from the calculation of diluted earnings per share for the periods ended September 30, 2025 and 2024.

For the nine months ended September 30, 2025 and 2024, the calculations of basic and diluted loss per share are the same because potential dilutive securities would have had an anti-dilutive effect. The potentially dilutive securities consisted of the following:

September 30, 2025September 30, 2024
Warrants1,863,0691,882,076
Options221,756146,202
Total2,084,8252,028,278

Cash and Cash Equivalents

For purposes of the statement of cash flows, we consider all highly liquid debt instruments purchased with an original maturity of three months or less to be cash equivalents.

The Company’s consolidated financial statements include the results of operations and financial position of its subsidiary located in Taiwan. The subsidiary’s functional currency is the Taiwan New Dollar (TWD). For consolidation purposes, the subsidiary’s financial statements are translated into US Dollars (USD) using the following methods: Assets and liabilities are translated using the exchange rate at the balance sheet date. Income statement items are translated using the average exchange rate for the period. Exchange rate fluctuations between TWD and USD result in gains or losses that are included in Other Comprehensive Income (Loss) until they are realized. The Company had $749,619 and $1,025,675 of its cash and cash equivalents in Taiwan New Dollars at September 30, 2025 and December 31, 2024, respectively.

Accounts Receivable

We provide an allowance for doubtful collections, which is based upon a review of outstanding receivables, historical collection information, and existing economic conditions. For our U.S.-based segment, receivables past due more than 120 days, if any, are considered delinquent. For our Taiwan-based segment, receivables over one year, if any, are considered delinquent. Delinquent receivables are written off based on individual credit valuation and specific circumstances of the customer. As of September 30, 2025 and December 31, 2024, no allowance for uncollectible accounts was deemed necessary.

Deferred Cost of Goods

In Taiwan we ship product to be held at the customer locations in advance of installment per the contract with the customer. We reclassify inventory that we have purchased and delivered to the customer location to Deferred Cost of Goods until this product is installed and can be invoiced to the customer.

Inventories

Inventory is stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out (“FIFO”) basis. We review our inventories for excess or obsolete products or components based on an analysis of historical usage and an evaluation of estimated future demand, market conditions, and alternative uses for possible excess or obsolete parts. There wasno allowance for slow-moving and obsolete inventory necessary as of September 30, 2025 and December 31, 2024, respectively.

Property and Equipment

Property and equipment are stated at cost. Depreciation is computed primarily using the straight-line method over estimated useful lives of three toseven years. Expenditures for routine maintenance and repairs are charged to expense as incurred. Depreciation expense for the nine months ended September 30, 2025 and 2024 was $16,062 and $15,806, respectively.

We have a relatively minimal amount of property and equipment, consisting primarily of office equipment. We review the recoverability of the carrying value of long-lived assets using the methodology prescribed in ASC 360 “Property, Plant and Equipment.” We review our long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. Recoverability of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the undiscounted future net operating cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying value of the assets exceeds their fair value. Management determined that there was no indicator of impairment as of September 30, 2025 and December 31, 2024.

Equity Method Investment

The Company accounts for investments in entities in which the Company has significant influence over the entity’s financial and operating policies, but does not control, using the equity method of accounting. The equity method investments are initially recorded at cost, and subsequently increased for capital contributions and allocations of net income, and decreased for capital distributions and allocations of net loss. Equity in net income (loss) from the equity method investment is allocated based on the Company’s economic interest. Equity method investments are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. If it is determined that a loss in value of the equity method investment is other than temporary, an impairment loss is measured based on the excess of the carrying amount of an investment over its estimated fair value. Impairment analyses are based on current plans, intended holding periods, and available information at the time the analysis is prepared. During 2023 the Company made a $180,000 investment for a 40% interest in Iveda Phils Joint Venture (located in the Philippines). Based on Management’s assessment, the value of its equity method investment was impaired as of December 31, 2023, and as such, recorded an impairment charge of $180,000. As of December 31, 2023 and 2024, the remaining value of its investments was $0. During the three months and nine months ended September 30, 2025 we had revenues to Iveda Phils JV of $155,750 and 188,445 for the three and nine months ended September 30, 2025, respectively..

Income Taxes

We are subject U.S. federal income and state income taxes, as well as Taiwan income taxes. During the three and nine months ended September 30, 2025 we incurred income tax expense of $665 and $30,443, respectively related to our Taiwan operations.

Deferred income taxes are recognized in the consolidated financial statements for the tax consequences in future years of differences between the tax basis of assets and liabilities and their financial reporting amounts based on enacted tax laws and statutory tax rates. Temporary differences arise from sales cut-off, depreciation, deferred rent expense, and net operating losses. Valuation allowances are established when necessary to reduce deferred tax assets to the amount that represents our best estimate of such deferred tax assets that, more likely than not, will be realized. Income tax expense is the tax payable for the year and the change during the year in deferred tax assets and liabilities.

Our U.S. income tax returns are subject to review and examination by federal, state, and local authorities. Our U.S. tax returns for the years 2020 to 2023 are open to examination by federal, local, and state authorities.

Our Taiwan tax returns are subject to review and examination by the Taiwan Ministry of Finance. Our Taiwan tax return for the years 2020 to 2023 are open to examination by the Taiwan Ministry of Finance.

Restricted Cash

Restricted cash represents time deposits on account to secure short-term bank loans in our Taiwan-based segment.

Stock-Based Compensation

The Company periodically issues stock, stock options and restricted stock awards to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on ASC 718, Compensation-Stock Compensation whereby the value of the award is measured on the date of grant and recognized for employees as compensation expense on the straight-line basis over the vesting period. Recognition of compensation expense for non-employees is in the same period and manner as if the Company had paid cash for the services. The fair value of the Company’s stock options is estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods.

Fair Value of Financial Instruments

The Company uses various inputs in determining the fair value of its financial assets and liabilities and measures these assets on a recurring basis. Financial assets recorded at fair value are categorized by the level of subjectivity associated with the inputs used to measure their fair value. Accounting Standards Codification Section 820 defines the following levels of subjectivity associated with the inputs:

Level 1—Quoted prices in active markets for identical assets or liabilities.

Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly.

Level 3—Unobservable inputs in which there is little or no market data for the asset or liability which requires the Company to develop its own assumptions.

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to us as of September 30, 2025 and December 31, 2024. The respective carrying values of certain on-balance-sheet financial instruments approximate their fair values. These financial instruments include cash, accounts receivable, accounts payable, accrued expenses, and amounts due to related parties. Fair values were assumed to approximate carrying values for these financial instruments because they are short-term in nature and their carrying amounts approximate their fair values or because they are receivable or payable on demand. The carrying values of financing obligations approximate their fair values because interest rates on these obligations are based on prevailing market interest rates.

New Accounting Standards

In November 2024, FASB issued ASU 2024-03 Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40) Disaggregation of Income Statement Expenses. The guidance in ASU 2024-03 requires public business entities to disclose in the notes to the financial statements, among other things, specific information about certain costs and expenses including purchases of inventory; employee compensation; and depreciation and amortization expense for each caption on the income statement where such expenses are included. The update is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted, and the amendments may be applied prospectively to reporting periods after the effective date or retrospectively to all periods presented in the financial statements. We are currently evaluating the provisions of this guidance and assessing the potential impact on our financial statement disclosures.

Other recent accounting pronouncements and guidance issued by the FASB, its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future financial statements.

NOTE 2 Accounts and Other Payables

September 30, 2025December 31, 2024
Accounts Payable$920,774$730,297
Accrued Expenses312,166981,769
Customer Deposits7,96236,791
Accounts and Other Payables$1,240,902$1,748,857

NOTE 3 SHORT-TERM AND LONG-TERM DEBT

The short-term debt balances were as follows:

September 30, 2025 · December 31, 2024
Loan from Shanghai Commercial Bank at 3.1%-3.2% interest rate per annum. Fully paid off in 2025. (1)$-$183,011
Loan from HuaNam Bank at 3.45% interest rate per annum. Due in July 2026.164,13491,505
Loan from ChangHwa Bank at 3% -3.3% interest rate per annum. Fully paid off in 2025.-152,509
Balance at end of period$164,134$427,025

As of September 30, 2025 and December 31, 2024, there was $32,802 and $29,013, respectively, of restricted cash pledged as security for the Shanghai Commercial Bank short term loan.

The Long-term debt balances were as follows:

Loans from Shanghai Commercial Bank with interest rates 2.1% per annum due January 2029 (1)$437,689$498,195
Current Portion of Long-term debt(131,307)(122,007)
Balance at end of period$306,382$376,188
(1)On January 24, 2024, the Company received a facility notice from Shanghai Commercial Bank, granting a revolving loan facility totaling up to TWD 10,000,000 (approximately $300,000 USD) and term loan facility amounting of TWD 20,000,000 (approximately ($600,000 USD). The term for the revolving loan is 1 year (and was fully paid off as of September 30, 2025) and for the term loan is 5 years. The 5 year term loan requires monthly payments including interest and principal, and the revolving loan requires a full principal repayment at the maturity date. The short-term Shanghai Commercial Bank loan is 75% securitized by the government guarantee fund called SME credit guarantee fund and 10% by saving deposit security. The guarantors of this loan are Mr. Siu and Mr. Cheung, who are both part of Iveda Taiwan’s management team.

NOTE 4 PREFERRED STOCK

We are currently authorized to issue up to 12,500,000 shares of preferred stock, par value $0.00001 per share,1,250,000 shares of which are designated as Series A Preferred Stock and 500 shares of which are designated as Series B Preferred Stock. Our Articles of Incorporation authorize the issuance of shares of preferred stock with designations, rights, and preferences determined from time to time by our Board of Directors. Accordingly, our Board of Directors is empowered, without stockholder approval, to issue preferred stock with dividend, liquidation, conversion, voting, or other rights which could adversely affect the voting power or other rights of the stockholders of our common stock. In the event of issuance, the preferred stock could be utilized, under certain circumstances, as a method of discouraging, delaying, or preventing a change in control of our company.

NOTE 5 COMMON STOCK

We are authorized to issue up to 300,000,000 shares of common stock, par value $0.00001 per share. We effectuated a reverse stock split on September 17, 2024 of 1 for 8 shares of common stock. All share values within this report have been retroactively adjusted to the post reverse split values. All outstanding shares of our common stock are of the same class and have equal rights and attributes. The holders of our common stock are entitled to one vote per share on all matters submitted to a vote of the stockholders of our company. Our common stock does not have cumulative voting rights. Persons who hold a majority of the outstanding shares of our common stock entitled to vote on the election of directors can elect all of the directors who are eligible for election. Holders of our common stock are entitled to share equally in dividends, if any, as may be declared from time to time by our Board of Directors. In the event of liquidation, dissolution, or winding up of our company, subject to the preferential liquidation rights of any series of preferred stock that we may from time to time designate, the holders of our common stock are entitled to share ratably in all of our assets remaining after payment of all liabilities and preferential liquidation rights. Holders of our common stock have no conversion, exchange, sinking fund, redemption, or appraisal rights (other than such as may be determined by the Board of Directors in its sole discretion) and have no preemptive rights to subscribe for any of our securities.

On September 4, 2024, We and a certain institutional investor (the “Investor”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) pursuant to which the Company agreed to sell and issue to the Investor in a registered direct offering (the “Offering”): (i)225,000 shares of common stock, par value $0.00001 per share (the “Common Stock”), at an offering price of $3.44 per share, and (ii) pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to 400,000 shares of Common Stock, at an offering price of $3.43 per Pre-Funded Warrant, to the investor whose purchase of Common Stock in this offering would otherwise result in the investor, together with its affiliates and certain related parties, beneficially own more than 4.99% (or at the election of the investor, 9.99%) of the Company’s outstanding common stock immediately following the consummation of this Offering. Each of the Pre-Funded Warrants were exercisable for one share of Common Stock. The Pre-Funded Warrants had an exercise price of $0.008 per share, were immediately exercisable, and all of the Pre-Funded Warrants were exercised in 2024. The Offering was made pursuant to an effective shelf registration statement on Form S-3 (File No. 333-276676) that was filed with the Securities and Exchange Commission (the “SEC”) on January 24, 2024 and declared effective by the SEC on February 7, 2024.

During 2025 we filed a Prospectus Supplement to the Prospectus dated January 24, 2024 to issue up to $5,082,431, from time to time through or to our sales agent, H.C. Wainwright & Co. (the “Agent”). These sales,were made pursuant to the terms of an At Market Issuance Sales Agreement, or the Sales Agreement, between us and the Agent (the “Sales Agreement”). As of September 30, 2025 we had completed the sale of 1,599,383 shares of common stock with net proceeds of $2,706,346. See Note 11 Subsequent Events for October 2025 disclosure of additional sales.

NOTE 6 STOCK OPTION PLANS

Stock Options

On January 18, 2010, we adopted the 2010 Stock Option Plan (the “2010 Option Plan”), which allows the Board to grant options to purchase up to 15,625 shares of common stock to directors, officers, key employees, and service providers of our company. In 2011, the 2010 Option Plan was amended to increase the number of shares issuable under the 2010 Option Plan to 375,000 shares. In 2012, 2010 Option Plan was again amended to increase the number of shares issuable under the 2010 Option Plan to 203,125 shares. The shares issuable pursuant to the 2010 Option Plan are registered with the SEC under Forms S-8 filed on February 4, 2010 (No. 333- 164691), June 24, 2011 (No. 333-175143), and December 4, 2013 (No. 333-192655). The 2010 Option Plan expired on January 18, 2020. As of September 30, 2025 there were 21,422 options outstanding under the 2010 Option Plan and as of December 31, 2024 there were 23,659 options outstanding under the 2010 Option Plan.

On December 15, 2020, we adopted the Iveda Solutions, Inc. 2020 Plan (the “2020 Plan”). The 2020 Plan had a maximum of 156,250 shares authorized with similar terms and conditions to the 2010 Option Plan. The shares issuable pursuant to the 2020 Option Plan are registered with the SEC under Forms S-8 filed on October 7, 2022 (No. 333- 267792). In 2024, the 2020 Option Plan was amended to increase the number of shares issuable under the 2020 Option Plan to 656,250 shares.

As of September 30, 2025 and December 31, 2024, there were 221,756 and 217,056 options outstanding, respectively, under all the option plans.

Stock options may be granted as either incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), or as options not qualified under Section 422 of the Code. All options are issued with an exercise price at or above the fair market value of the common stock on the date of the grant as determined by our Board of Directors. Incentive stock option plan awards of restricted stock are intended to qualify as deductible performance-based compensation under Section 162(m) of the Code. Incentive Stock Option awards of unrestricted stock are not designed to be deductible to us under Section 162(m). Under the plans, stock options will terminate on the tenth anniversary date of the grant or earlier if provided in the grant.

We have also granted non-qualified stock options to employees and contractors. All non-qualified options are generally issued with an exercise price no less than the fair value of the common stock on the date of the grant as determined by our Board of Directors. Options may be exercised up to ten years following the date of the grant, with vesting schedules determined by us upon grant. Vesting schedules vary by grant, with some fully vesting immediately upon grant to others that ratably vest over a period of time up to four years. Standard vested options may be exercised up to three months following date of termination of the relationship unless alternate terms are specified at grant. The fair values of options are determined using the Black-Scholes option-pricing model. The estimated fair value of options is recognized as expense on the straight-line basis over the options’ vesting periods.

Stock option transactions during nine months ended September 30, 2025 were as follows:

SharesWeighted- Average Exercise Price
Outstanding at Beginning of Period217,05618.56
Granted10,0002.15
Exercised--
Forfeited or Cancelled(5,300)22.40
Outstanding at End of Period221,75617.72
Options Exercisable at Period-End213,006$18.37

During the nine months ended September 30, 2025 the Company granted options to acquire 10,000 shares of our common stock with a fair value of $16,573 or based on a Black-Scholes valuation model. During the nine month periods ended September 30, 2025 and 2024 the Company recognized $0 and $25,600 of compensation cost relating to the vesting of options.

Information with respect to stock options outstanding and exercisable at September 30, 2025 is as follows:

Options Outstanding · Options Exercisable
Range of Exercise PricesNumber Outstanding at September 30, 2025Weighted- Average Remaining Contractual LifeWeighted- Average Exercise PriceNumber Exercisable at September 30, 2025Weighted- Average Exercise Price
$1.43-142.08221,7567.3$17.72212,225$18.37

The fair value of each option granted is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions used for options granted.

Expected Life6.25 yrs
Expected Volatility90%
Risk-Free Interest Rate4.00%

NOTE 7 WARRANTS

Warrants

Warrant transactions during the nine months ended September 30, 2025 were as follows:

SharesWeighted-Average Exercise Price
Outstanding at Beginning of Period1,882,076$9.42
Granted--
Exercised--
Forfeited or Cancelled(19,007)37.79
Outstanding at End of Period1,863,0699.13
Warrant Exercisable at Period-End1,863,0699.13
Weighted-Average Fair Value of Warrants Granted During the Period$-

Information with respect to warrants outstanding and exercisable at September 30, 2025 is as follows:

Warrants Outstanding · Warrants Exercisable
Range of Exercise PricesNumber Outstanding at September 30, 2025Weighted- Average Remaining Contractual LifeWeighted- Average Exercise PriceNumber Exercisable at September 30, 2025Weighted- Average Exercise Price
$3.44 -$34.001,863,0692.3$9.131,863,069$9.13

The fair value of each warrant granted is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions used for options granted.

As of September 30, 2025 there were 1,863,069 outstanding. For the nine months ended September 30, 2025 there wereno warrants granted and 19,007 warrants cancelled.

NOTE 8 LEASES

The Company accounts for its leases in accordance with the guidance of ASC 842,Leases. The Company determines whether a contract is, or contains, a lease at inception. Right-of-use assets represent the Company’s right to use an underlying asset during the lease term, and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at lease commencement based upon the estimated present value of unpaid lease payments over the lease term. The Company uses its incremental borrowing rate based on the information available at lease commencement in determining the present value of unpaid lease payments.

In 2025, the Company entered into a long-term non-cancellable lease agreement for its facility that requires aggregate average monthly payments of $4,540 beginning March 2025 through February 2029. On the date of the lease, the Company determined that the value of the new right of use asset and lease liability was $182,668, respectively, using a discount rate of 8%. During the period ended September 30, 2025, the Company reflected amortization of the right of use assets of $23,405 related to the lease, resulting in a net asset balance of $159,263 as of September 30, 2025. During the period ended September 30, 2025, the Company made combined aggregate payments of $33,050 related to these leases, of which $15,267 was reflected as a reduction in the lease liabilities. As of September 30, 2025 the lease liability amounted to $167,413.

NOTE 9 COMMITMENTS AND CONTINGENCIES

The Company may be involved in certain legal proceedings that arise from time to time in the ordinary course of our business. Except for income tax contingencies, we record accruals for contingencies to the extent that our management concludes that the occurrence is probable and that the related amounts of loss can be reasonably estimated. Management believes the accompanying financial statements include all provisions, of any, for any potential losses. Legal expenses associated with the contingency are expensed as incurred.

On September 13, 2024 Aegis Capital Corp. commenced an action againstthe Company alleging that it had breached the provisions of a Placement Agency Agreement (PPA) dated June 24, 2024 and that the Company was required to pay the plaintiff placement agent fees as a result of the Company’s September 4, 2024 direct offering of $2.15 million with H. C. Wainwright. The Company rejects the Plaintiff’s claims that it is due the 7% plus expenses in the PPA and asserts that the PAA had been terminated on August 15, 2024 due to the plaintiff’s non-performance and that the plaintiff is not entitled to any fees in the offering since it raised none of the funds in the offering. The parties have agreed to a mutually agreeable settlement amount to cancel the action which has been provided for in the accompanying September 30, 2025 financial statements.

Pursuant to certain contracts with Chicony Power Technology Co., Ltd., Shihlin Electric & Engineering Corporation, National Chung Shan Institute of Science and Technology and Chung-Hsin Electric and Machinery Manufacturing Corp., Iveda Taiwan is required to provide after-project services. If Iveda Taiwan fails to provide these after-project services in the future, other parties of the related contract would have recourse. The financial exposure to Iveda Taiwan in the event of failure to provide after- project services in the future as of September 30, 2025 is $396,133.

NOTE 10 SEGMENT INFORMATION

The Company operates and manages its business astwo reportable and operating segments. The Company’s CODM reviews financial information presented and decides how to allocate resources based on net income (loss). Net income (loss) is used for evaluating financial performance.

Significant segment expenses include salaries and payroll, marketing, public company expenses, audit and accounting, consulting, research and development, travel and entertainment, software subscription and other administrative expenses for the US and salaries and payroll, rent, travel and entertainment, and other administrative expenses. The following table presents the significant segment expenses and other segment items regularly reviewed by our CODM.

ConsolidatedUSTaiwanConsolidatedUSTaiwan
Three Months Ended September 30, 2025 · Three Months Ended September 30, 2024
Revenues$1,651,787$76,929$1,574,858$2,398,162$313,969$2,084,193
Cost of Goods Sold1,134,51061,0861,073,4241,987,680256,5011,731,179
Gross Profit517,27715,843501,434410,48257,468353,014
31%21%32%17%18%17%
Operating Expenses
Salaries and Payroll Expenses350,987226,529124,459351,086257,83493,252
Travel and Entertainment129,963112,07317,890131,745115,26416,481
Marketing84,38384,383-99,18799,187-
Public Company expenses81,43281,432-35,63635,636-
Audit and Accounting27,75227,752-91,72491,724-
Research and Development25,75025,75039,25039,250
Rent(24,884)(36,923)12,03921,38211,03110,351
Other operating expenses56,1976,85049,347249,404210,45838,946
Total Operating Expenses731,580527,846203,7341,019,415860,384159,031
Loss (Income) from Operations(214,303)(512,003)297,700(608,932)(802,916)193,984
Interest Income and Other (Expenses), net(6,386)(2,469)(3,917)27,4286,24821,180
Net loss before Income Tax(220,689)(514,472)293,783(581,504)(796,668)215,164
Income Tax Expense(615)-(615)131-131
Net loss$(221,304)$(514,472)$293,168$(581,373)$(796,668)$215,295
ConsolidatedUSTaiwanConsolidatedUSTaiwan
Nine Months Ended September 30, 2025 · Nine Months Ended September 30, 2024
Revenues$4,654,270$697,032$3,957,238$4,278,983$629,028$3,649,955
Cost of Goods Sold3,404,012522,3982,881,6143,185,443498,5932,686,850
Gross Profit1,250,258174,6341,075,6241,093,540130,435963,105
27%25%27%26%21%26%
Operating Expenses
Salaries and Payroll Expenses1,074,466754,572319,8941,017,208741,839275,369
Travel and Entertainment395,170350,01645,154400,266360,45139,815
Marketing253,482253,482-324,629324,629-
Public Company expenses141,722141,722-460,224460,224-
Audit and Accounting303,411303,411-278,718278,718-
Research and Development110,250110,250-339,350339,350-
Rent52,82817,59135,237106,53074,63831,892
Other operating expenses501,151367,181133,970715,824562,066153,759
Total Operating Expenses2,832,4802,298,225534,2553,642,7493,141,915500,834
Loss (Income) from Operations(1,582,222)(2,123,591)541,369(2,549,209)(3,011,480)462,271
Interest Income and Other (Expenses), net44,24135,183(1,744)111,72181,63530,086
Net loss before Income Tax(1,548,782)(2,088,407)539,625(2,437,486)(2,929,843)492,357
Income Tax Expense(30,443)$(50)(30,393)(32,464)(1,697)(30,767)
Net loss$(1,579,225)$(2,088,457)$509,232$(2,469,950)$(2,931,540)$461,590

Furthermore, due to operations in various geographic locations, we are susceptible to changes in national, regional, and local economic conditions, demographic trends, consumer confidence in the economy, and discretionary spending priorities that may have a material adverse effect on our future operations and results.

We are required to collect certain taxes and fees from customers on behalf of government agencies and remit them back to the applicable governmental agencies on a periodic basis. The taxes and fees are legal assessments to the customer, for which we have a legal obligation to act as a collection agent. Because we do not retain the taxes and fees, we do not include such amounts in revenue. We record a liability when the amounts are collected and relieve the liability when payments are made to the applicable governmental agencies.

The Net Revenues for our significant geographic regions are as follows:

Net Revenues
For the Nine months endedFor the Nine months ended
September 30, 2025September 30, 2024
United States$697,032$629,028
Republic of China (Taiwan)$3,957,238$3,649,955
Total Consolidated$4,654,270$4,278,983

The net assets (liabilities) for our significant geographic regions are as follows:

Net Assets (Liabilities)
As ofAs of
September 30, 2025December 31, 2024
United States$2,426,986$1,775,554
Republic of China (Taiwan)$1,341,256$729,885
Total Consolidated$3,768,242$2,505,439

NOTE 11 SUBSEQUENT EVENTS

The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the financial statements are available to be issued. Any material events that occur between the balance sheet date and the date that the financial statements were available for issuance are disclosed as subsequent events, while the financial statements are adjusted to reflect any conditions that existed at the balance sheet date.

The Company sold 1,373,809 shares of common stock in October 2025 for net proceeds of $2,224,048 via the ATM with H.C. Wainwright effectively closing out the February 27, 2025 S-3 prospectus supplement.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.